Clinical trials show progress in migraine frequency, skin cancer prevention
-
0:48
People honor service members during Memorial Day ceremony in...
-
1:57
39th annual Family Kite Festival soars over Milwaukee’s lakefront
-
0:26
Community leader Lucille Berrien passes away at age 98
-
5:21
Some speech and sleep concerns in children may be more connected...
-
0:59
Rainbow Springs Nature Preserve
-
5:05
Volunteer Positions at WHS Racine Campus
-
7:34
Sip, Sing, & Safari and more at The Racine Zoo!
-
6:33
Reviews of ’Star Wars: The Mandalorian and Grogu’ and ’Your...
-
4:41
Sargento employee from St. Cloud designated prestigious ‘Wisconsin...
-
2:56
Milwaukee students design their own shoes, step-by-step
-
5:50
Cedarburg family continues to shape the legacy of The Gem Shop
-
3:04
Right on cue. Summerlike weather for the unofficial start of...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.